Entering text into the input field will update the search result below

Adaptimmune Therapeutics plc (ADAP) Q4 2022 Earnings Call Transcript

Mar. 06, 2023 3:40 PM ETAdaptimmune Therapeutics plc (ADAP)
SA Transcripts profile picture
SA Transcripts

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2022 Earnings Conference Call March 6, 2023 8:00 AM ET

Company Participants

Juli Miller - Head-Investor Relations

Adrian Rawcliffe - Chief Executive Officer

Garry Menzel - President and Chief Executive Officer, TCR2 Therapeutics

Conference Call Participants

Ernie Rodriguez - Cowen

Mara Goldstein - Mizuho

Tony Butler - EF Hutton

Michael Schmidt - Guggenheim

Jonathan Chang - SVB Securities

Asthika Goonewardene - Truist Securities

Kelly Shi - Jefferies

Soumit Roy - Jones Research

Yanan Zhu - Wells Fargo Securities

Peter Lawson - Barclays


Welcome to Adaptimmune and TCR2 joint webcast to discuss their strategic combination announced earlier this morning.

I will turn the call over to Juli Miller, VP of Investor Relations and Corporate Affairs at Adaptimmune. Juli?

Juli Miller

Thank you, operator. Hello. Good morning. We issued a joint press release with TCR2 Therapeutics, announcing entry into an agreement for the strategic combination of our two companies. In the second press release, we provided our Q4 and full-year 2022 financial and business updates. I would ask you to review the full text of the forward-looking statements. We anticipate making projections during this webcast, and actual results could differ materially due to several factors, including those outlined in our latest filings with the SEC, as well as our 10-K filing for the year ended 2022, which will be filed later today. Of note, we will share slides during this webcast, which are also available on the presentations tab of our Investor Relations website.

Adrian Rawcliffe, our Chief Executive Officer, and Garry Menzel, TCR2 Therapeutics President and Chief Executive Officer are here with me for the prepared portion of the call, as well as Q&A.

With that, I'll turn the call over to Adrian Rawcliffe. Ad?

Adrian Rawcliffe

Thanks, Juli. We're delighted to welcome you to this webcast

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.